|
|
| MRD / Regn No. |
: THBC\23-24\02527 |
Date |
: 15/07/2026 |
| Patient Name |
: Manoj Satia |
Age & Gender |
: 60 Yrs. / Male |
| Contact No. |
: 9769000040 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (12/Nov/2014) | |
|
Subjective |
: |
T2DM SINCE 2014/ ANGIOPLASTY DONE IN 2017,DID NOT TOLERATE SGLT2 / IMEGLIMIN / SEMAGLUTIDE
|
|
Objective |
: |
08-JUL-2026 REPORTS,AMYLASE-107.5,FBS-96,HB-12.6,HSCRP-1.32,FERRITIN 72.5,HBA1C-5.80%,ALT-40/ AST-44,LIPASE-128.1,TC-112/ TG-60/ LDL-59/ HDL-41,CR-0.72,T3-124/ T4-8.02/ TSH-2.4,VITB12-1005/ VITD-33.7,ACR-43.21 |
|
Analysis |
: |
ECOSPRIN 75 MG / ROSEDAY EZ 40/10 MG |
|
Plan |
: |
WILL CONTINUE OZEMPIC 1 MG TILL BACK FROM AUSTRIA |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
SAROGLITAZAAR 4 MG
LIPAGLYN 4 MG |
ORAL |
1-0-0 |
ABF
|
3 MTHS |
|
|
2 |
TELLZY 40 MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
3 |
TABLET GLICLAZIDE (30MG) AND METFORMIN (500MG)
DIAMICRON XR MEX 30+500 MG |
ORAL |
1-0-1 |
BBF / BD
|
3 MTHS |
|
|
4 |
HOMOCHEK |
ORAL |
0-1-0 |
ALT DAY
|
3 MTHS |
|
|
5 |
INJ OZEMPIC 1 MG |
SC |
1/WEEKLY |
ANYTIME OF DAY
|
3 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 05/Jun/2026 |
| Tests Suggested For Next Visit |
: TO INFORM ME IF TOLERATES 1 MG - CAN CONSIDER GOING UPTO 1.7 MG,CHECK HBA1C TO DOCUMENT REDUCTION |
| |
|
| |
|
Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra /
2003/05/2166
This is a Computer generated Prescription |
Powered By:  |
|